Contact Us | Legal

Press Releases

PGNX - (NASDAQ)
$4.80   - 0.01
Jun 19, 2013
4:00 PM ET
News Feeds
= Add Release to Briefcase
All Releases
View Summary Salix and Progenics Announce FDA Advisory Committee to Review Relistor sNDA for Opioid-Induced Constipation in Patients with Chronic Pain
Jun 11, 2013
PDF 16.0 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Presents PSMA-Related Data at SNMMI 2013
Jun 10, 2013
PDF 20.0 KB Add to Briefcase
View Summary Progenics Pharmaceuticals' Data From a Phase 1 Study of PSMA ADC Presented at ASCO 2013
Jun 1, 2013
PDF 20.5 KB Add to Briefcase
View Summary Progenics Pharmaceuticals to Present at Jefferies Global Healthcare Conference
May 31, 2013
PDF 16.3 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Added to the NASDAQ Biotechnology Index
May 17, 2013
PDF 14.8 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Announces First Quarter 2013 Financial Results
May 10, 2013
PDF 24.5 KB Add to Briefcase
View Summary Progenics Pharmaceuticals to Host Conference Call to Review First Quarter 2013 Financial Results on May 10
May 6, 2013
PDF 13.7 KB Add to Briefcase
View Summary Progenics Pharmaceuticals to Present at Needham Healthcare Conference
Apr 24, 2013
PDF 16.7 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Announces Fourth Quarter and Year-End 2012 Financial Results
Mar 15, 2013
PDF 27.9 KB Add to Briefcase
View Summary Progenics Pharmaceuticals to Host Conference Call to Review Fourth Quarter Financial Results on March 15
Mar 8, 2013
PDF 13.8 KB Add to Briefcase
View Summary Progenics Pharmaceuticals' Novel Small Molecule Drugs Targeting PSMA Successfully Visualize Prostate Cancer
Mar 5, 2013
PDF 21.3 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Presents Updated Data From Phase 1 Study of PSMA ADC
Feb 14, 2013
PDF 18.3 KB Add to Briefcase
View Summary Progenics Acquires Molecular Insight Pharmaceuticals to Expand Oncology-Focused Pipeline
Jan 22, 2013
PDF 18.5 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Nov 29, 2012
PDF 20.7 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Announces Proposed Public Offering of Common Stock
Nov 28, 2012
PDF 20.2 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Announces Third Quarter 2012 Financial Results
Nov 8, 2012
PDF 31.5 KB Add to Briefcase
View Summary Progenics Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
Nov 6, 2012
PDF 17.1 KB Add to Briefcase
View Summary Progenics Pharmaceuticals to Host Conference Call to Review Third Quarter Financial Results on November 8
Nov 2, 2012
PDF 13.8 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Initiates Phase 2 Clinical Trial of PSMA ADC in Prostate Cancer Patients
Sep 28, 2012
PDF 21.0 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Provides Corporate Update
Sep 20, 2012
PDF 20.4 KB Add to Briefcase
Showing 1-20 of 165 releases Page: 1 2 3 4 5 6 7 8 9  See Next 20